These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 32975758)
21. Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations. Prata J; Santos SG; Almeida MI; Coelho R; Barbosa MA J Neuroinflammation; 2017 Sep; 14(1):179. PubMed ID: 28870209 [TBL] [Abstract][Full Text] [Related]
22. Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker? Sneeboer MAM; van der Doef T; Litjens M; Psy NBB; Melief J; Hol EM; Kahn RS; de Witte LD Schizophr Res; 2020 Jan; 215():167-172. PubMed ID: 31699629 [TBL] [Abstract][Full Text] [Related]
23. Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Meyer U; Schwarz MJ; Müller N Pharmacol Ther; 2011 Oct; 132(1):96-110. PubMed ID: 21704074 [TBL] [Abstract][Full Text] [Related]
31. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Notter T; Coughlin JM; Gschwind T; Weber-Stadlbauer U; Wang Y; Kassiou M; Vernon AC; Benke D; Pomper MG; Sawa A; Meyer U Mol Psychiatry; 2018 Feb; 23(2):323-334. PubMed ID: 28093569 [TBL] [Abstract][Full Text] [Related]
32. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. Tardy M; Huhn M; Kissling W; Engel RR; Leucht S Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009268. PubMed ID: 25007358 [TBL] [Abstract][Full Text] [Related]
33. Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia. MacDowell KS; Munarriz-Cuezva E; Caso JR; Madrigal JL; Zabala A; Meana JJ; García-Bueno B; Leza JC Neuropharmacology; 2017 Apr; 116():196-207. PubMed ID: 28039001 [TBL] [Abstract][Full Text] [Related]
34. Neuronal injury in chronic CNS inflammation. Zindler E; Zipp F Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866 [TBL] [Abstract][Full Text] [Related]
35. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Svensson TH Brain Res Brain Res Rev; 2000 Mar; 31(2-3):320-9. PubMed ID: 10719159 [TBL] [Abstract][Full Text] [Related]
36. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
37. Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring - the effect of antipsychotic drugs. Basta-Kaim A; Szczęsny E; Leśkiewicz M; Głombik K; Slusarczyk J; Budziszewska B; Regulska M; Kubera M; Nowak W; Wędzony K; Lasoń W Pharmacol Rep; 2012; 64(6):1400-10. PubMed ID: 23406750 [TBL] [Abstract][Full Text] [Related]
38. Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia. Yoshida K; Takeuchi H Behav Brain Res; 2021 Mar; 402():113098. PubMed ID: 33417992 [TBL] [Abstract][Full Text] [Related]
39. Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review. de Bartolomeis A; Barone A; Vellucci L; Mazza B; Austin MC; Iasevoli F; Ciccarelli M Mol Neurobiol; 2022 Oct; 59(10):6460-6501. PubMed ID: 35963926 [TBL] [Abstract][Full Text] [Related]
40. Clinical potential of minocycline for schizophrenia. Miyaoka T CNS Neurol Disord Drug Targets; 2008 Oct; 7(4):376-81. PubMed ID: 18991666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]